The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival characteristics of patients with first progression of glioblastoma at Cleveland Clinic Foundation.
 
Yasmeen Rauf
No Relationships to Disclose
 
Jimmy Yao
No Relationships to Disclose
 
Addison Barnett
No Relationships to Disclose
 
Yanwen Chen
No Relationships to Disclose
 
Brian Hobbs
Stock and Other Ownership Interests - Presagia
Consulting or Advisory Role - Simulstat
Research Funding - Amgen
(OPTIONAL) Uncompensated Relationships - Presagia
 
Glen Stevens
No Relationships to Disclose
 
David M. Peereboom
Consulting or Advisory Role - Orbus Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Mylan (Inst); Neonc Technologies (Inst); Novartis (Inst); Orbus Therapeutics (Inst); Pfizer (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - Stemline Therapeutics
 
Manmeet Singh Ahluwalia
Stock and Other Ownership Interests - doctible; MimiVax
Honoraria - Elsevier; Peerview; Prime Education; Prime Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Flatiron Health; FORMA Therapeutics; Kadmon; Karyopharm Therapeutics; Tocagen; Varian Medical Systems; VBI Vaccines
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); MimiVax (Inst); Novartis (Inst); Novocure (Inst); Pharmacyclics (Inst)